These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 11734183

  • 21. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
    Barton CL, Hutson PH.
    Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
    [Abstract] [Full Text] [Related]

  • 22. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I, Bel N, Fernández AG, Palacios JM, Artigas F.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [Abstract] [Full Text] [Related]

  • 23. 5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex.
    Malagié I, Trillat AC, Bourin M, Jacquot C, Hen R, Gardier AM.
    J Neurochem; 2001 Feb; 76(3):865-71. PubMed ID: 11158258
    [Abstract] [Full Text] [Related]

  • 24. The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.
    De Groote L, Olivier B, Westenberg HG.
    Eur J Pharmacol; 2002 Mar 29; 439(1-3):93-100. PubMed ID: 11937097
    [Abstract] [Full Text] [Related]

  • 25. Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat.
    Hervás I, Queiroz CM, Adell A, Artigas F.
    Br J Pharmacol; 2000 May 29; 130(1):160-6. PubMed ID: 10781012
    [Abstract] [Full Text] [Related]

  • 26. The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
    Pullar IA, Boot JR, Broadmore RJ, Eyre TA, Cooper J, Sanger GJ, Wedley S, Mitchell SN.
    Eur J Pharmacol; 2004 Jun 16; 493(1-3):85-93. PubMed ID: 15189767
    [Abstract] [Full Text] [Related]

  • 27. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724
    [Abstract] [Full Text] [Related]

  • 28. Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study.
    Dawson LA, Nguyen HQ, Smith DI, Schechter LE.
    Br J Pharmacol; 2000 Jun 07; 130(4):797-804. PubMed ID: 10864885
    [Abstract] [Full Text] [Related]

  • 29. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder.
    el Mansari M, Bouchard C, Blier P.
    Neuropsychopharmacology; 1995 Oct 07; 13(2):117-27. PubMed ID: 8597523
    [Abstract] [Full Text] [Related]

  • 30. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
    Matzen L, van Amsterdam C, Rautenberg W, Greiner HE, Harting J, Seyfried CA, Böttcher H.
    J Med Chem; 2000 Mar 23; 43(6):1149-57. PubMed ID: 10737747
    [Abstract] [Full Text] [Related]

  • 31. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.
    de Groote L, Olivier B, Westenberg HG.
    Psychopharmacology (Berl); 2002 Aug 23; 162(4):419-24. PubMed ID: 12172696
    [Abstract] [Full Text] [Related]

  • 32. Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo.
    Stenfors C, Magnusson T, Larsson LG, Yu H, Hållbus M, Magnusson O, Ross SB.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Feb 23; 359(2):110-6. PubMed ID: 10048595
    [Abstract] [Full Text] [Related]

  • 33. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
    Knobelman DA, Hen R, Blendy JA, Lucki I.
    J Pharmacol Exp Ther; 2001 Sep 23; 298(3):1092-100. PubMed ID: 11504806
    [Abstract] [Full Text] [Related]

  • 34. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H, Wang W, Jiang Z, Shang J, Zhang L.
    Arzneimittelforschung; 2010 Sep 23; 60(3):109-15. PubMed ID: 20422941
    [Abstract] [Full Text] [Related]

  • 35. SB-236057-A: a selective 5-HT1B receptor inverse agonist.
    Roberts C, Watson J, Price GW, Middlemiss DN.
    CNS Drug Rev; 2001 Sep 23; 7(4):433-44. PubMed ID: 11830759
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex.
    Yoshino T, Nisijima K, Katoh S, Yui K, Nakamura M.
    Neurochem Int; 2002 Apr 23; 40(4):355-60. PubMed ID: 11792466
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of the 5-HT1D receptor antagonist GR127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis.
    Skingle M, Sleight AJ, Feniuk W.
    Neuropharmacology; 1995 Apr 23; 34(4):377-82. PubMed ID: 7566468
    [Abstract] [Full Text] [Related]

  • 40. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I.
    J Pharmacol Exp Ther; 2002 Sep 23; 302(3):1220-7. PubMed ID: 12183683
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.